Lipoprotein (a) in an immigrant Indian population sample in Australia

References

• McKeigue PM, Miller GJ, Marmot MG. Coronary heart disease in south Asians overseas: a review. J Clin Epidemiol 1989; 42: 597–609.
   Google Scholar
• Misra A. Atherosclerosis in Indians and lipoprotein (a). JAPI 1999; 47: 313–7.
   Google Scholar
• Seedat YK, Mayet FG, Khan S, Somers SR, Joubert G. Risk factors for coronary heart disease in the Indians of Durban. South African Medical Journal 1990; 78: 447–54.
   Google Scholar
• Thomas I, Gupta S, Sempos C, Cooper R. Serum lipids of Indian physicians living in the US compared to US-born physicians. Atherosclerosis 1986; 61: 99–106.
   Google Scholar
• Hughes LO. Insulin, Indian origin and ischaemic heart disease. Int J Cardiol 1990; 26: 1–4.
   Google Scholar
• Laws A, Jeppesen JL, Maheux PC, Schaaf P, Chen YD, Reaven GM. Resistance to insulin-stimulated glucose uptake and dyslipidemia in Asian Indians. Arterioscler Thromb 1994; 14: 917–22.
   Google Scholar
• Gambhir JK, Kaur H, Gambhir DS, Prabhu KM. Lipoprotein(a) as an independent risk factor for coronary artery disease in patients below 40 years of age. Indian Heart J 2000; 52: 411–5.
   Google Scholar
• Mohan V, Deepa R, Haranath SP et al. Lipoprotein(a) is an independent risk factor for coronary artery disease in NIDDM patients in South India. Diabetes Care 1998; 21: 1819–23.
   Google Scholar
• Berg K. A new serum type system in man – the Lp system. Acta Pathol Microbiol Scand 1963; 59: 369–82.
   Google Scholar
• Armstrong VW, Cremer P, Eberle E et al. The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis. Dependence on serum LDL levels. Atherosclerosis 1986; 62: 249–57.
   Google Scholar
• Danesh J, Collins R, Peto R. Lipoprotein(a) and coronary heart disease. Meta-analysis of prospective studies. Circulation 2000; 102: 1082–5.
   Google Scholar
• Simons LA. Lipoprotein(a): important risk factor or passing fashion? Med J Aust 1993; 158: 512–4.
   Google Scholar
• Utermann G. The mysteries of lipoprotein(a). Science 1989; 246: 904–10.
   Google Scholar
• Soma M, Fumagalli R, Paoletti R et al. Plasma Lp(a) concentration after oestrogen and progestagen in postmenopausal women. Lancet 1991; 337: 612.
   Google Scholar
• Crouse JR, 3rd. New developments in the use of niacin for treatment of hyperlipidemia: new considerations in the use of an old drug. Coron Artery Dis 1996; 7: 321–6.
   Google Scholar
• Falco C, Tormo G, Estelles A et al. Fibrinolysis and lipoprotein(a) in women with coronary artery disease. Influence of hormone replacement therapy. Haematologica 2001; 86: 92–8.
   Google Scholar
• Marcovina SM, Koschinsky ML. Lipoprotein(a) as a risk factor for coronary artery disease. Am J Cardiol 1998; 82: 57U-66U. (Discussion, 86U).
   Google Scholar
• Cobbaert C, Mulder P, Lindemans J, Kesteloot H. Serum LP(a) levels in African Aboriginal Pygmies and Bantus, compared with Caucasian and Asian population samples. J Clin Epidemiol 1997; 50: 1045–53.
   Google Scholar
• Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499–502.
   Google Scholar
• Wang XL, Wilcken DE, Dudman NP. An indirect sandwich ELISA for LP(a) in serum and dried blood spots. Clin Chim Acta 1992; 207: 73–86.
   Google Scholar
• Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; i: 307–10.
   Google Scholar
• Sandholzer C, Hallman DM, Saha N et al. Effects of the apolipoprotein(a) size polymorphism on the lipoprotein(a) concentration in 7 ethnic groups. Hum Genet 1991; 86: 607–14.
   Google Scholar
• Hoogeveen RC, Gambhir JK, Gambhir DS et al. Evaluation of Lp(a) and other independent risk factors for CHD in Asian Indians and their USA counterparts. J Lipid Res 2001; 42: 631–8.
   Google Scholar
• Anand SS, Enas EA, Pogue J, Haffner S, Pearson T, Yusuf S. Elevated lipoprotein(a) levels in South Asians in North America. Metabolism 1998; 47: 182–4.
   Google Scholar
• Craig WY, Poulin SE, Forster NR, Neveux LM, Wald NJ, Ledue TB. Effect of sample storage on the assay of lipoprotein(a) by commercially available radial immunodiffusion and enzyme-linked immunosorbent assay kits. Clin Chem 1992; 38: 550–3.
   Google Scholar
• Jauhiainen M, Koskinen P, Ehnholm C et al. Lipoprotein (a) and coronary heart disease risk: a nested case-control study of the Helsinki Heart Study participants. Atherosclerosis 1991; 89: 59–67.
   Google Scholar
• Evans RW, Sankey SS, Hauth BA, Sutton-Tyrrell K, Kamboh MI, Kuller LH. Effect of sample storage on quantitation of lipoprotein(a) by an enzyme-linked immunosorbent assay. Lipids 1996; 31: 1197–203.
   Google Scholar
• Kronenberg F, Trenkwalder E, Dieplinger H, Utermann G. Lipoprotein(a) in stored plasma samples and the ravages of time. Why epidemiological studies might fail. Arterioscler Thromb Vasc Biol 1996; 16: 1568–72.
   Google Scholar
• Cobbaert C, Kesteloot H. Serum lipoprotein(a) levels in racially different populations. Am J Epidemiol 1992; 136: 441–9.
   Google Scholar
• Khan MA, Baseer A. Lipoprotein(a) status in coronary heart disease. JPMA 2000; 50: 47–50.
   Google Scholar